September 1992
Volume 33, Issue 10
Free
Articles  |   September 1992
Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
Author Affiliations
  • C Baudouin
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
  • F Brignole
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
  • D Fredj-Reygrobellet
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
  • F Nègre
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
  • J Bayle
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
  • P Gastaud
    Department of Ophthalmology, Saint-Roch Hospital, Nice, France.
Investigative Ophthalmology & Visual Science September 1992, Vol.33, 2822-2829. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C Baudouin, F Brignole, D Fredj-Reygrobellet, F Nègre, J Bayle, P Gastaud; Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.. Invest. Ophthalmol. Vis. Sci. 1992;33(10):2822-2829.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

Immunotoxins directed against a membrane marker of cell proliferation, transferrin receptor, were investigated to inhibit the growth of retinal pigment epithelial (RPE) cells in proliferative vitreoretinopathy (PVR). We undertook an immunocytological study in specimens of vitreous, subretinal fluid, and epiretinal membranes from patients with PVR to address the expression of transferrin receptor by proliferating pigment epithelial cells during the course of PVR and in normal human ocular structures. Thirty four specimens of vitreous and subretinal fluid, as well as seven epiretinal membranes, were immunocytologically examined using monoclonal antibodies to transferrin receptor. They showed a strong expression of this marker by a large majority of the cells in these two periretinal fluids (mean percentages 80 and 91% in vitreous and subretinal fluid, respectively). In contrast, only a few cells within epiretinal membranes were found to express transferrin receptor. In normal human eye sections conjunctival and corneal epithelial cells, subcapsular epithelium of the lens strongly expressed transferrin receptor, whereas RPE cells remained negative to antitransferrin receptor antibodies. A few iris or ciliary pigment epithelial cells reacted weakly. Thus, this study shows that most intravitreal and subretinal fluid proliferating cells strongly express transferrin receptor on their surface. Also confirmed is that immunotoxins to this membrane antigen could constitute potentially useful therapeutic agents in PVR.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×